CALC CalciMedica, Inc.
Company Analysis
Latest News
π΄ CalciMedica is trading 5% down in pre-market amid extreme volatility after its reverse stock split
CalciMedica is trading 5% down in pre-market at $1.90 after extreme volatility following its 1-for-5 reverse stock split. - CalciMedica closed September 1,...
π’ CalciMedica is trading 10.57% up in after-hours trading
CalciMedica is trading 10.57% up at $2.21 after closing September 1, 2026, at $2.00, with no clear company-specific announcement or late-breaking catalyst...
π΄ CalciMedica is trading 6% down today amid biotech-sector weakness
CalciMedica is trading at $2.01, with a -6.07% change amid a broad September 1, 2026 risk-off session and biotech-sector weakness. - The S&P 500 is down 0.79%...
π’ CalciMedica is trading 5.14% up today after Stonepine Capital expanded stake to 6.00%
CalciMedica is trading 5.14% up at $2.25 after Stonepine Capital Management expanded its position on August 19, 2026, bringing ownership to 6.00%. - The...
π’ CalciMedica is trading 5.1% up in pre-market after Stonepine Capital Management expands stake
CalciMedica is trading at $2.25, up 5.14% in pre-market following significant post-split volatility. * Stonepine Capital Management expanded its stake in...
π’ CalciMedica is trading 12.53% up in after-hours trading after completing a 1-for-5 reverse stock split
CalciMedica is trading $2.41 (+12.53%) after completing a 1-for-5 reverse stock split. β’ The reverse split became effective at 5:00 p.m. ET on August 28,...
π’ CalciMedica is trading 6.54% up today in after-hours trading following 1-for-5 reverse stock split
CalciMedica is trading 6.54% up now at $2.28 in after-hours trading following its 1-for-5 reverse stock split. - Effective 5:00 p.m. ET, August 28, 2026. -...
π΄ CalciMedica is trading 5.9% down today after a 1-for-5 reverse stock split
CalciMedica is trading 5.9% down at $2.19 after the 1-for-5 reverse stock split became effective at 5:00 p.m. ET on August 28, 2026. - Split-adjusted trading...
π΄ CalciMedica is trading 6% down in pre-market after its 1-for-5 reverse stock split took effect
CalciMedica is trading at $2.18 (-6.12%) after its 1-for-5 reverse stock split became effective after the August 28, 2026 close at 5:00 p.m. ET; the reverse...
π΄ CalciMedica is trading 6.1% down today after announcing a 1-for-5 reverse stock split
CalciMedica is trading at $0.44, down 6.1%, after announcing a 1-for-5 reverse stock split. β’ The announcement followed a 20.00% decline on August 27; company...
CalciMedica Announces 1-for-5 Reverse Stock Split and Reduction of Authorized Shares
CalciMedica, Inc. filed a Certificate of Amendment to enact a 1-for-5 reverse stock split of its common stock, effective at 5:00 p.m. ET on August 28, 2026....
CalciMedica's Reverse Stock Split Buys Time on Nasdaq, but Can a Sub-Dollar Biotech Survive the Signal It Sends?
Shares of CalciMedica (CALC) tumbled 14.9% to $0.50 on August 27, 2026, after the clinical-stage biotech announced a one-for-five reverse stock split β a move...
π΄ CalciMedica is trading 14.89% down today after announcing a reverse split to restore Nasdaq compliance
CalciMedica is trading at $0.50 (-14.89%) after announcing a one-for-five reverse stock split intended to restore compliance with Nasdaqβs minimum bid-price...
π΄ CalciMedica is trading 9.74% down today as immediate catalyst remains unclear
CalciMedica is trading 9.74% down now at $0.53 after no verified company-specific announcement dated August 26 or August 27 was identified. - The latest...
π΄ CalciMedica is trading 9.79% down in pre-market; no verified company-specific catalyst identified
CalciMedica is trading 9.79% down at $0.53, with no verified company-specific catalyst identified. - It closed at $0.59 on August 26, 2026; no verified...
π’ CalciMedica is trading 5.53% up in after-hours trading with no verified new company announcement
CalciMedica is trading 5.53% up in after-hours trading at $0.62 after closing at $0.59 on August 26, 2026, with no verified new company-specific catalyst. -...
π’ CalciMedica, Inc. is trading 5.03% up
CALC is trading at $0.58, up 5.03%.
π’ CalciMedica is trading 5% up in pre-market after Guggenheim's Buy rating and $9.00 target
CalciMedica is trading 5.12% up in pre-market at $0.60 after Guggenheim initiated coverage with a Buy rating and a $9.00 price target on August 20, 2026. -...
π’ CalciMedica is trading 6.65% up in after-hours trading after Guggenheim's Buy initiation
CalciMedica is trading 6.65% up at $0.62 after Guggenheim initiated coverage on August 20, 2026, with a Buy rating and a $9.00 price target. - The positive...
π΄ CalciMedica is trading 5.6% down today after reverse split approval
CalciMedica is trading 5.6% down at $0.58 after shareholders approved a reverse stock split ranging from 1-for-2 to 1-for-10 and expanded the companyβs equity...